CHRS|Coherus BioSciences Inc|Price:1.410|Chg%:-0.020
Coherus BioSciences Inc (CHRS) shows relatively healthy fundamentals and high growth potential, though its stock price is expected to trend down in the medium term. The company's valuation is considered fair, ranking 97 out of 155 in the Pharmaceuticals industry, with strong institutional ownership. …